Ziprasidone (Geodon, Zeldox)
Indications
Pharmacology
Metabolism
Administration
Dose Adjustment
Adverse Effects
Cardiovascular Adverse Effects
QT Prolongation without Definite Association with Torsade (see Torsade, [[Torsade]])
Dermatologic Adverse Effects
Drug Rash with Eosinophilia and Systemic Symptoms (DRESS) (Drug-Induced Hypersensitivity Syndrome, DIHS) (see Drug Rash with Eosinophilia and Systemic Symptoms)
- Epidemiology: FDA warning issued 2015 (related to 6 reported cases of DRESS syndrome)
- Clinical: onset occurred between day 11-30 of drug initiation
- Prognosis: no reported deaths
Other Adverse Effects
References